Publication | Closed Access

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

MedicineImmunologyPathologyColorectal CancerImmune Checkpoint InhibitorPiccasso PhaseCancer TreatmentCancer GeneticsOncologyRadiation Oncology